Výsledky vyhledávání - "Kulikauskas RM"

Akademický článek

Characterization of Immunosuppressive Myeloid Cells in Merkel Cell Carcinoma: Correlation with Resistance to PD-1 Pathway Blockade.

Autor: Tabachnick-Cherny S; Department of Dermatology, University of Washington, Seattle, Washington., Pulliam T; Department of Dermatology, University of Washington, Seattle, Washington., Rodriguez HJ; Department of Dermatology, University of Washington, Seattle, Washington., Fan X; Fred Hutchinson Cancer Center, Seattle, Washington., Hippe DS; Fred Hutchinson Cancer Center, Seattle, Washington., Jones DC; Fred Hutchinson Cancer Center, Seattle, Washington., Moshiri AS; Department of Dermatology, New York University, New York, New York., Smythe KS; Fred Hutchinson Cancer Center, Seattle, Washington., Kulikauskas RM; Department of Dermatology, University of Washington, Seattle, Washington., Zaba LC; Department of Dermatology, Stanford University School of Medicine, Palo Alto, California., Paulson KG; Paul G Allen Research Center, Providence-Swedish Cancer Institute, Seattle, Washington., Nghiem P; Department of Dermatology, University of Washington, Seattle, Washington.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Mar 15; Vol. 30 (6), pp. 1189-1199.

Zobrazit plný text záznamu

Akademický článek

Prevalent and Diverse Intratumoral Oncoprotein-Specific CD8 ⁺ T Cells within Polyomavirus-Driven Merkel Cell Carcinomas.

Autor: Jing L; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington., Ott M; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington., Church CD; Division of Dermatology, Department of Medicine, University of Washington, Seattle, Washington., Kulikauskas RM; Division of Dermatology, Department of Medicine, University of Washington, Seattle, Washington., Ibrani D; Division of Dermatology, Department of Medicine, University of Washington, Seattle, Washington., Iyer JG; Division of Dermatology, Department of Medicine, University of Washington, Seattle, Washington., Afanasiev OK; Division of Dermatology, Department of Medicine, University of Washington, Seattle, Washington., Colunga A; Division of Dermatology, Department of Medicine, University of Washington, Seattle, Washington., Cook MM; Division of Dermatology, Department of Medicine, University of Washington, Seattle, Washington., Xie H; Department of Laboratory Medicine, University of Washington, Seattle, Washington., Greninger AL; Department of Laboratory Medicine, University of Washington, Seattle, Washington., Paulson KG; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington.; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Chapuis AG; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington.; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Bhatia S; Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, Washington.; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Nghiem P; Division of Dermatology, Department of Medicine, University of Washington, Seattle, Washington.; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington., Koelle DM; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington. dkoelle@medicine.washington.edu.; Department of Laboratory Medicine, University of Washington, Seattle, Washington.; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Department of Global Health, University of Washington, Seattle, Washington.; Benaroya Research Institute, Seattle, Washington.

Publikováno v: Cancer immunology research [Cancer Immunol Res] 2020 May; Vol. 8 (5), pp. 648-659. Date of Electronic Publication: 2020 Mar 16.

Zobrazit plný text záznamu

Akademický článek

Human CD4 ⁺ T Cells Specific for Merkel Cell Polyomavirus Localize to Merkel Cell Carcinomas and Target a Required Oncogenic Domain.

Autor: Longino NV; Department of Medicine, Division of Dermatology, University of Washington, Seattle, Washington.; Department of Pathology, University of Washington, Seattle, Washington., Yang J; Translational Research Program, Benaroya Research Institute at Virginia Mason, Seattle, Washington., Iyer JG; Department of Medicine, Division of Dermatology, University of Washington, Seattle, Washington., Ibrani D; Department of Medicine, Division of Dermatology, University of Washington, Seattle, Washington., Chow IT; Translational Research Program, Benaroya Research Institute at Virginia Mason, Seattle, Washington., Laing KJ; Department of Medicine, Division of Allergy and Infectious Disease, University of Washington, Seattle, Washington., Campbell VL; Department of Medicine, Division of Allergy and Infectious Disease, University of Washington, Seattle, Washington., Paulson KG; Department of Medicine, Division of Dermatology, University of Washington, Seattle, Washington.; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, Washington., Kulikauskas RM; Department of Medicine, Division of Dermatology, University of Washington, Seattle, Washington., Church CD; Department of Medicine, Division of Dermatology, University of Washington, Seattle, Washington., James EA; Translational Research Program, Benaroya Research Institute at Virginia Mason, Seattle, Washington., Nghiem P; Department of Medicine, Division of Dermatology, University of Washington, Seattle, Washington. pnghiem@uw.edu.; Department of Pathology, University of Washington, Seattle, Washington., Kwok WW; Translational Research Program, Benaroya Research Institute at Virginia Mason, Seattle, Washington., Koelle DM; Translational Research Program, Benaroya Research Institute at Virginia Mason, Seattle, Washington.; Department of Medicine, Division of Allergy and Infectious Disease, University of Washington, Seattle, Washington.; Department of Laboratory Medicine, University of Washington, Seattle, Washington.; Department of Global Health, University of Washington, Seattle, Washington.; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.

Publikováno v: Cancer immunology research [Cancer Immunol Res] 2019 Oct; Vol. 7 (10), pp. 1727-1739. Date of Electronic Publication: 2019 Aug 12.

Zobrazit plný text záznamu

Akademický článek

WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors.

Autor: Anastas JN, Kulikauskas RM, Tamir T, Rizos H, Long GV, von Euw EM, Yang PT, Chen HW, Haydu L, Toroni RA, Lucero OM, Chien AJ, Moon RT

Publikováno v: The Journal of clinical investigation [J Clin Invest] 2014 Jul; Vol. 124 (7), pp. 2877-90. Date of Electronic Publication: 2014 May 27.

Zobrazit plný text záznamu

Akademický článek

Targeted BRAF inhibition impacts survival in melanoma patients with high levels of Wnt/β-catenin signaling.

Autor: Chien AJ; Division of Dermatology, University of Washington Department of Medicine, Seattle, Washington, United States of America; The Group Health Research Institute, Seattle, Washington, United States of America., Haydu LE; Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia., Biechele TL; Division of Dermatology, University of Washington Department of Medicine, Seattle, Washington, United States of America., Kulikauskas RM; Division of Dermatology, University of Washington Department of Medicine, Seattle, Washington, United States of America., Rizos H; Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Westmead Institute for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia., Kefford RF; Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Westmead Institute for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Westmead Hospital, Sydney, New South Wales, Australia., Scolyer RA; Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia., Moon RT; The Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America., Long GV; Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Westmead Institute for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Westmead Hospital, Sydney, New South Wales, Australia.

Publikováno v: PloS one [PLoS One] 2014 Apr 14; Vol. 9 (4), pp. e94748. Date of Electronic Publication: 2014 Apr 14 (Print Publication: 2014).

Zobrazit plný text záznamu

Akademický článek

In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.

Autor: Gavilan HS; Department of Biology, Duke University, Durham, North Carolina, United States of America., Kulikauskas RM; Department of Biology, Duke University, Durham, North Carolina, United States of America., Gutmann DH; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, United States of America., Fehon RG; Department of Molecular Genetics and Cell Biology, University of Chicago, Chicago, Illinois, United States of America.

Publikováno v: PloS one [PLoS One] 2014 Mar 04; Vol. 9 (3), pp. e90853. Date of Electronic Publication: 2014 Mar 04 (Print Publication: 2014).

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání